Skip to main content
SYRE logo

SYRE · Spyre Therapeutics, Inc.

$97.87 -2.09 (-2.09%) At close · Jul 29
Market Cap
$8.50B
Shares
86.84M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 201
Total Value: $4,164,680,870
Total Shares: 82,391,024
Showing 1–100 of 204 holdings by value · page 1 of 3

Institutional Ownership Trend

12 quarters

Holder Concentration

Across 198 13F filers
Top Holder
14.3%
Sep 2023 → Mar 2026 · range 13.5% – 24.6%
of institutional value
Top 5
35.5%
Sep 2023 → Mar 2026 · range 35.5% – 62.0%
of institutional value
Top 10
52.6%
Sep 2023 → Mar 2026 · range 52.6% – 87.4%
of institutional value
HHI
444
Sep 2023 → Mar 2026 · range 444 – 1,122
Broadly held
Showing 100 of 204
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1636282 CUSIP 00773J202 13F (30d) 25 filings 25 filers Visit website Investor relations